4 ms·
A nice idea to get something back from such companies is to have them collect data of the patients and gave back to the original company/copyright owner etc.
by iamgopal 14y ago
A nice idea to get something back from such companies is to have them collect data of the patients and gave back to the original company/copyright owner etc.
- carbocation 14y agoWhat you are describing is postmarketing surveillance ('phase IV clinical trial'). In the US, this is overseen by the FDA.
- iamgopal 14y agoIndia's huge market could give lots of data point for analysis. My opinion was to look for other opportunities to take advantage of such situation.